Boston Scientific Acquires Atritech for $375,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6635efb2-5d0b-417d-910d-ceb9161dd6ec&Preview=1 -
Date
1/19/2011 -
Company Name
Atritech -
Mailing Address
3750 Annapolis Lane Plymouth, MN 55447 -
Company Description
Atritech is an emerging medical device company focused on preventing atrial fibrillation (AF) related stroke through technology. -
Website
http://www.atritech.net -
Transaction Type
M&A -
Transaction Amount
$375,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
The agreement calls for an upfront payment of $100 million plus additional potential payments of up to $275 million upon achievement of specified regulatory and revenue-based milestones through 2015. The purchase price assumes no cash and no debt on Atritech’s balance sheet at closing.
